Raxibacumab

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 71655-103
  • Package NDC 71655-103-01
  • Application number BLA125349
  • SPL ID 5b24ce09-93c6-115b-e063-6394a90aa9f2
  • SPL set ID f6927e91-bb46-47b3-ab66-f9d8a9d7b12a
  • UNII 794PGL549S
  • RxCUI 1366571

What the source publishes

Labeler
Emergent BioDefense Operations Lansing
Active ingredients
raxibacumab
Form
INJECTION
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:71655-103_5b24ce09-93c6-115b-e063-6394a90aa9f2
{
  "name": "Raxibacumab",
  "splId": "5b24ce09-93c6-115b-e063-6394a90aa9f2",
  "labels": [
    {
      "setId": "f6927e91-bb46-47b3-ab66-f9d8a9d7b12a",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f6927e91-bb46-47b3-ab66-f9d8a9d7b12a",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f6927e91-bb46-47b3-ab66-f9d8a9d7b12a"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "Emergent BioDefense Operations Lansing",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 VIAL, SINGLE-USE in 1 CARTON (71655-103-01)  / 34 mL in 1 VIAL, SINGLE-USE",
      "package_ndc": "71655-103-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20121214"
    }
  ],
  "productId": "71655-103_5b24ce09-93c6-115b-e063-6394a90aa9f2",
  "useDomain": "unknown",
  "dosageForm": "INJECTION",
  "productNdc": "71655-103",
  "deaSchedule": null,
  "genericName": "raxibacumab",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "RAXIBACUMAB",
      "strength": "50 mg/mL"
    }
  ],
  "applicationNumber": "BLA125349",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20121214",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000192703",
      "N0000192702"
    ],
    "upc": [
      "0371655103010"
    ],
    "unii": [
      "794PGL549S"
    ],
    "rxcui": [
      "1366571"
    ],
    "spl_set_id": [
      "f6927e91-bb46-47b3-ab66-f9d8a9d7b12a"
    ],
    "pharm_class_epc": [
      "Anthrax Protective Antigen-directed Antibody [EPC]"
    ],
    "pharm_class_moa": [
      "Anthrax Protective Antigen-directed Antibody Interactions [MoA]"
    ],
    "manufacturer_name": [
      "Emergent BioDefense Operations Lansing"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:71655-103_5b24ce09-93c6-115b-e063-6394a90aa9f2"